Search results for "EPOR"

showing 10 items of 2839 documents

Cataracts and statins. A disproportionality analysis using data from VigiBase.

2019

The basis of the association between statin use and cataract has been explored using the World Health Organization (WHO) global database of individual case safety reports (ICSRs) for drug monitoring (VigiBase) through January 2019. The reporting odds ratios (RORs) as a measure of disproportionality for reported cataracts and individual statins have been calculated. Subgroup analyses according statin lipophilicity, sex, and age groups have been performed. Moreover, RORs have been calculated for non-statin lipid lowering drugs. An increased disproportionality have been found for most individual statins lovastatin: [ROR: 14.80, 95% confidence interval (CI): 13.30, 16.46)], atorvastatin (ROR: 3…

AdultMalemedicine.medical_specialtyStatinAdolescentmedicine.drug_classAtorvastatin010501 environmental sciencesToxicology030226 pharmacology & pharmacy01 natural sciencesRisk AssessmentCataract03 medical and health sciencesPharmacovigilanceYoung Adult0302 clinical medicineEzetimibeInternal medicinemedicineOdds RatioAdverse Drug Reaction Reporting SystemsHumansRosuvastatinChild0105 earth and related environmental sciencesAgedAged 80 and overbusiness.industryIncidenceGeneral MedicineOdds ratioMiddle AgedSimvastatinFemaleDrug MonitoringHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessPravastatinmedicine.drugFluvastatinRegulatory toxicology and pharmacology : RTP
researchProduct

The Intracranial Distribution of Gliomas in Relation to Exposure From Mobile Phones: Analyses From the INTERPHONE Study

2016

When investigating the association between brain tumors and use of mobile telephones, accurate data on tumor position are essential, due to the highly localized absorption of energy in the human brain from the radio-frequency fields emitted. We used a point process model to investigate this association using information that included tumor localization data from the INTERPHONE Study (Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Sweden, and the United Kingdom). Our main analysis included 792 regular mobile phone users diagnosed with a glioma between 2000 and 2004. Similar to earlier results, we found a statistically significant association …

AdultMalemedicine.medical_specialtyTELEPHONENeoplasms Radiation-InducedTime FactorsEpidemiologyOriginal ContributionsTumor burdenBrain tumorAudiologyMOBILE TELEPHONES03 medical and health sciences0302 clinical medicinePhoneRisk FactorsRecall biasEXPOSITION AU RISQUECERVEAUMedicineHumans030212 general & internal medicineEpidemiologic researchSelf reportONDERADIO-FREQUENCY ELECTROMAGNETIC FIELDSbusiness.industryBrain NeoplasmsINTERPHONE STUDYMiddle Agedmedicine.diseaseTumor BurdenMobile phone030220 oncology & carcinogenesisEpidemiologic Research DesignGLIOMAFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSPATIAL POINT PATTERNNeoplasm GradingbusinessINTRACRANIAL DISTRIBUTIONCell PhoneTUMEUR
researchProduct

Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study

2017

AIM To report adalimumab (Ada) efficacy on articular-gastrointestinal disease and health-related quality of life (HRQoL) in patients with enteropathic spondyloarthritis (ES). METHODS A cohort of 52 patients with ES was evaluated in the departments of gastroenterology and internal medicine. At baseline, all patients underwent assessment by an integrated gastro-rheumatologic evaluation of articular and gastrointestinal activity, as well patient reported outcomes (PROs) of the HRQoL questionnaires. After this integrated evaluation and following a specific working flowchart, the Ada anti-tumor necrosis factor (TNF)-inhibitor was assigned to a cohort of 30 patients and its clinical efficacy was …

AdultMalemedicine.medical_specialtyTime FactorsTumor necrosis factor-inhibitorMultidisciplinary studyObservational StudyInflammatory bowel diseasesInflammatory bowel diseaseWorkflowEnteropathic spondyloarthriti03 medical and health sciences0302 clinical medicineCrohn DiseaseClinimetric assessmentInternal medicineSpondylarthritisTumor necrosis factor-inhibitorsAdalimumabHumansMedicinePatient Reported Outcome MeasuresPatient reported outcomes030203 arthritis & rheumatologyBiological ProductsTumor Necrosis Factor-alphabusiness.industryRemission InductionAdalimumabGastroenterologyInflammatory Bowel DiseasesGeneral MedicineMiddle AgedPatient reported outcomeEnteropathic spondyloarthritisClinimetric assessment; Enteropathic spondyloarthritis; Inflammatory bowel diseases; Multidisciplinary evaluation; Patient reported outcomes; Tumor necrosis factor-inhibitors; GastroenterologyTreatment OutcomeMultidisciplinary evaluationAntirheumatic AgentsCritical PathwaysQuality of LifeColitis UlcerativeFemale030211 gastroenterology & hepatologyObservational studybusinessmedicine.drug
researchProduct

The costs of social anxiety disorder: The role of symptom severity and comorbidities

2013

Abstract Background Social anxiety disorder (SAD) is associated with low direct costs compared to other anxiety disorders while indirect costs tend to be high. Mental comorbidities have been identified to increase costs, but the role of symptom severity is still vague. The objective of this study was to determine the costs of SAD, and to explore the impact of symptoms and comorbidities on direct and indirect costs. Methods Baseline data, collected within the SOPHO-NET multi-centre treatment study ( N =495), were used. Costs were calculated based on health care utilization and lost productivity. Symptom severity was measured with the Liebowitz-Social-Anxiety-Scale; comorbidities were include…

AdultMalemedicine.medical_specialtyTotal costPopulationComorbidityEfficiencySeverity of Illness IndexYoung Adult03 medical and health sciencesIndirect costs0302 clinical medicineCost of IllnessAbsenteeismmental disordersHealth caremedicineHumans030212 general & internal medicineSocial BehaviorPsychiatryeducationhealth care economics and organizationseducation.field_of_studybusiness.industrySocial anxietyMiddle Agedmedicine.diseaseAnxiety Disorders3. Good health030227 psychiatryPsychiatry and Mental healthClinical PsychologyEating disordersAbsenteeismAnxietyFemaleSelf Reportmedicine.symptomPsychologybusinessJournal of Affective Disorders
researchProduct

Burkitt lymphoma associated with human immunodeficiency virus infection and pulmonary tuberculosis: A case report.

2019

Abstract Introduction: The association of human immunodeficiency virus (HIV) infection with Burkitt lymphoma is related to the presence of Epstein Barr virus infection and the impact of the HIV antigen on the expansion of B-polyclonal cells. In Southeast Europe, the association is rare, and recognizing this is important in the therapeutic decision to increase patient survival rate. The association of HIV with Burkitt lymphoma and tuberculosis is even more rarely described in the literature. Patient concerns: We present the case of a 40-year-old patient who presented with a 3-week history of fever (max. 38.7 °C), painful axillary swelling on the right side, lumbar pain, gait disorders, heada…

AdultMalemedicine.medical_specialtyTuberculosisAntitubercular AgentsAntineoplastic AgentsHIV Infectionshuman immunodeficiency virus infectionNeurosurgical ProceduresMycobacterium tuberculosis03 medical and health sciences0302 clinical medicinePharmacotherapyFatal Outcomeimmune system diseasesInternal medicinehemic and lymphatic diseasesAntiretroviral Therapy Highly ActivemedicineHumans030212 general & internal medicineClinical Case ReportEpstein–Barr virus infectionTuberculosis PulmonaryImmunodeficiencydose-adjusted etoposide doxorubicin and cyclophosphamide with vincristine prednisone and rituximabbiologyClinical Deteriorationbusiness.industry4900BrainBurkitt lymphomaGeneral MedicineViral Loadhighly active antiretroviral therapymedicine.diseasebiology.organism_classificationDecompression SurgicalLymphomaCD4 Lymphocyte CountSpinal Cord030220 oncology & carcinogenesisSputummedicine.symptombusinessViral loadpulmonary tuberculosisResearch ArticleMedicine
researchProduct

Blood and urinary abnormalities induced during and after 24-hour continuous running: A case report

2016

In this reported clinical case, a healthy and well-trained male subject [aged 37 years, maximal oxygen uptake (V[Combining Dot Above]O2max) 64 mL·kg·min] ran for 23 hours and 35 minutes covering 160 km (6.7 km/h average running speed). The analysis of hematological and biochemical parameters 3 days before the event, just after termination of exercise, and after 24 and 48 hours of recovery revealed important changes on muscle and liver function, and hemolysis. The analysis of urine sediments showed an increment of red and white blood cells filtrations, compatible with transient nephritis. After 48 hours, most of these alterations were recovered. Physicians and health professionals who monito…

AdultMalemedicine.medical_specialtyUrinary systemPhysiologyPhysical Therapy Sports Therapy and RehabilitationUrine030204 cardiovascular system & hematologyHemolysisRunning03 medical and health sciences0302 clinical medicineAtletamedicineHumansOrthopedics and Sports MedicineMuscle SkeletalPathologicalNephritisbusiness.industryMedicina deportivaVO2 max030229 sport sciencesAtletasmedicine.diseaseHemolysisSurgeryLiverClinical caseLiver functionbusinessNephritisBiomarkers
researchProduct

The Urticaria Activity Score-Validity, Reliability, and Responsiveness.

2018

Background Chronic spontaneous urticaria is characterized by fluctuating symptoms. Its activity is assessed with the urticaria activity score (UAS). Two versions of the urticaria activity score used for 7 consecutive days (UAS7) are available: (1) The guideline-recommended UAS7, with once-daily documentation, and (2) the UAS7TD, with twice-daily documentation. Objective To better characterize both UAS7 versions with regard to their validity, reliability, sensitivity to change, minimal important difference (MID), and smallest detectable change (SDC). Methods One hundred thirty adult patients with chronic spontaneous urticaria completed both UAS7 versions, the Patients Global Assessment (PatG…

AdultMalemedicine.medical_specialtyUrticariaIntraclass correlationOmalizumabOmalizumabSeverity of Illness IndexDisease activity030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeimmune system diseasesInternal medicineAnti-Allergic AgentsImmunology and AllergyMedicineHumansskin and connective tissue diseasesReceiver operating characteristicbusiness.industryReproducibility of ResultsDermatology Life Quality IndexMiddle AgedStandard error030228 respiratory systemChronic DiseasePhysical therapyPatient-reported outcomeFemalebusinessmedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct

Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study

2021

ObjectiveThis study aimed to develop and validate a patient-reported outcome measure (PROM) in acute pancreatitis (AP) as an endpoint centred on the patient.DesignA PROM instrument (PAtieNt-rePoRted OutcoMe scale in acute pancreatItis, an international proSpEctive cohort study, PAN-PROMISE scale) was designed based on the opinion of patients, professionals and an expert panel. The scale was validated in an international multicentre prospective cohort study, describing the severity of AP and quality of life at 15 days after discharge as the main variables for validation. The COSMIN (COnsensus-based Standards for the selection of health status Measurement INstruments) methodology was applied.…

AdultMalemedicine.medical_specialtyacute pancreatitisOrdinal ScalePromCohort Studies03 medical and health sciences0302 clinical medicinePredictive Value of TestsCriterion validitymedicineHumansPatient Reported Outcome Measures030212 general & internal medicineProspective cohort studyReliability (statistics)AgedFace validityHospital Prof. Dr. Fernando Fonseca E.P.E.business.industryGastroenterologyReproducibility of ResultsPAN-PROMISE study.Middle AgedHospitalizationClinical trialClinical trialPancreatitisQuality of LifePhysical therapyFemale030211 gastroenterology & hepatologyPatient-reported outcomeSymptom AssessmentbusinessGut
researchProduct

The rates of co-occurring behavioural addictions in treatment-seeking individuals with obsessive-compulsive disorder: a preliminary report

2020

Objectives: To assess the rates of co-occurring putative ‘behavioural addictions’ in patients with obsessive-compulsive disorder (OCD). Methods: Twenty-three international centres specialising in the treatment of OCD were invited to participate in a survey of the rates of behavioural addictions and other relevant comorbidity within their samples. Results: Sixteen of 23 (69.6%) invited centres from 13 countries had sufficient data to participate in the survey. The use of validated diagnostic tools was discrepant, with most centres relying on a ‘clinical diagnosis’ to diagnose behavioural addictions. The final sample comprised of 6916 patients with a primary diagnosis of OCD. The reported rat…

AdultMalemedicine.medical_specialtybehavioural addictionsAdolescentSexual Behaviormedia_common.quotation_subjectDiagnosis; behavioural addictions; obsessive-compulsive disorderbehavioural addictionComorbidityDiagnostic toolsYoung Adult03 medical and health sciences0302 clinical medicineCo occurringObsessive compulsivePreliminary reportmental disordersDiagnosismedicineHumansPsychiatrymedia_commonTreatment seekingAddictionMiddle Agedmedicine.diseaseComorbidity030227 psychiatryBehavior Addictiveobsessive-compulsive disorderPsychiatry and Mental healthVideo Gamesbehavioural addictions; Diagnosis; obsessive-compulsive disorderClinical diagnosisGamblingFemalePsychologyInternet Addiction Disorder030217 neurology & neurosurgeryDiagnosi
researchProduct

Patient-Reported Nonadherence with Glaucoma Therapy

2019

Abstract Purpose: Effective glaucoma therapy relies to a great extent on the patients' ability to regularly self-administer eye drops. This study aimed to assess self-reported nonadherence and to identify potential barriers to adherence in glaucoma patients. Methods: Participants completed a 16-item questionnaire, designed to examine nonadherence rate and assess the therapy experience. Inclusion criteria stipulated treatment duration of at least 1 year. Nonadherence was defined as missing ≥5% of the prescribed pressure-lowering eye drops doses. Results: In total, 201 glaucoma patients aged 24–88 years were included. Mean treatment duration was 9.4 years. Nonadherence was reported by 30.3% o…

AdultMalemedicine.medical_specialtygenetic structuresGlaucomaoutcomesYoung AdultGermanySurveys and QuestionnairesmedicineHumansPharmacology (medical)adherencePatient Reported Outcome MeasuresIntensive care medicineAntihypertensive AgentsAgedPharmacologyAged 80 and overnonadherencebusiness.industryPreservatives PharmaceuticalGlaucomaOriginal ArticlesMiddle Agedmedicine.diseaseeye diseasesOphthalmologyside effectsPatient ComplianceFemalesense organspreservativesInjections IntraocularOphthalmic SolutionsbusinessJournal of Ocular Pharmacology and Therapeutics
researchProduct